Talphera Q3 2026 Earnings Preview (NASDAQ:TLPH)
Talphera (TLPH) will report Q3 2026 earnings on November 12th. Analysts expect an EPS of -$0.06. The company has beaten EPS estimates 75% of the time in the past year, with 1 recent upward revision.
How this was made

The 30-second read
Why it matters
The earnings preview provides the first public consensus estimate, setting expectations for the upcoming release.
Market read
The preview sets the market tone for TLPH and may affect related biotech stocks.
What to watch
Upcoming clinical trial updates or partnership news not mentioned could offset earnings disappointment.
Background
Talphera is a micro‑cap biotech with a history of mixed earnings performance.
Ticker impact
Talphera (TLPH) will report Q3 earnings on Nov 12 after market close with a consensus EPS estimate of -$0.06.
likely pressure as the market prices in the weak EPS forecast
Investors will react to the earnings surprise; a miss could trigger a sell‑off, while a beat may limit downside.
Market effects
Talphera operates in the biotech sector; earnings could influence peer sentiment.
US biotech market may see modest movement based on the result.
Limited to investors tracking small‑cap biotech earnings.
Counterpoint
If the company surprises to the upside, the stock could rally sharply despite the negative consensus.
Key entities
- CompanyTalphera
US‑listed biotech (NASDAQ:TLPH) reporting Q3 2026 earnings.


